Logo image of CIIT

TIANCI INTERNATIONAL INC (CIIT) Stock Fundamental Analysis

NASDAQ:CIIT - Nasdaq - US88631G2057 - Common Stock - Currency: USD

1.05  -0.01 (-0.94%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CIIT. CIIT was compared to 0 industry peers in the Unkown industry. The financial health of CIIT is average, but there are quite some concerns on its profitability. CIIT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CIIT has reported negative net income.
In the past year CIIT has reported a negative cash flow from operations.
In the past 5 years CIIT reported 4 times negative net income.
In multiple years CIIT reported negative operating cash flow during the last 5 years.
CIIT Yearly Net Income VS EBIT VS OCF VS FCFCIIT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200K -200K -400K -600K -800K -1M

1.2 Ratios

Industry RankSector Rank
ROA -2.56%
ROE -3.53%
ROIC 4.12%
ROA(3y)-403.78%
ROA(5y)-417.31%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CIIT Yearly ROA, ROE, ROICCIIT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K -2K

1.3 Margins

Industry RankSector Rank
OM 0.37%
PM (TTM) N/A
GM 10.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CIIT Yearly Profit, Operating, Gross MarginsCIIT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

More info and screens

6

2. Health

2.1 Basic Checks

Compared to 1 year ago, CIIT has more shares outstanding
Compared to 5 years ago, CIIT has more shares outstanding
CIIT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CIIT Yearly Shares OutstandingCIIT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
CIIT Yearly Total Debt VS Total AssetsCIIT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K

2.2 Solvency

An Altman-Z score of 54.57 indicates that CIIT is not in any danger for bankruptcy at the moment.
CIIT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 54.57
ROIC/WACCN/A
WACCN/A
CIIT Yearly LT Debt VS Equity VS FCFCIIT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200K -200K 400K -400K 600K

2.3 Liquidity

CIIT has a Current Ratio of 4.52. This indicates that CIIT is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 4.52 indicates that CIIT has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 4.52
Quick Ratio 4.52
CIIT Yearly Current Assets VS Current LiabilitesCIIT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 105.05% over the past year.
The Revenue has grown by 1804.80% in the past year. This is a very strong growth!
EPS 1Y (TTM)105.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
Revenue 1Y (TTM)1804.8%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%124.69%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CIIT Yearly Revenue VS EstimatesCIIT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2M 4M 6M 8M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
CIIT Price Earnings VS Forward Price EarningsCIIT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CIIT Per share dataCIIT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CIIT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TIANCI INTERNATIONAL INC

NASDAQ:CIIT (8/1/2025, 8:00:00 PM)

1.05

-0.01 (-0.94%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners3.27%
Ins Owner ChangeN/A
Market Cap17.36M
AnalystsN/A
Price TargetN/A
Short Float %0.06%
Short Ratio0.03
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.69
P/FCF N/A
P/OCF N/A
P/B 26.75
P/tB 26.75
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0.62
BVpS0.04
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.56%
ROE -3.53%
ROCE 5.46%
ROIC 4.12%
ROICexc 7.68%
ROICexgc 7.68%
OM 0.37%
PM (TTM) N/A
GM 10.22%
FCFM N/A
ROA(3y)-403.78%
ROA(5y)-417.31%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover11.46
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.52
Quick Ratio 4.52
Altman-Z 54.57
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)105.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1804.8%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%124.69%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y148.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y86.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y86.65%
OCF growth 3YN/A
OCF growth 5YN/A